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Research on pathological calcifications constitutes an exciting topic at the interface between physics, chemistry and medicine. The relationship 
between their physicochemical characteristics and the pathology responsible for their formation offers a unique opportunity to perform a sig-
nificant medical diagnosis, to assess the interaction between drugs and these biological entities as well as to develop new drugs. Regarding syn-
chrotron radiation, the emergence of microbeam allows the clinician to perform an early diagnosis. Indeed, we will start this review with a clinical 
case where Fourier transform infrared spectroscopy using synchrotron radiation as a probe allowed the clinician to save the kidney function of a 
patient. Following this example, we will see that investigations on pathological calcifications constitute an elegant way to gather major information 
on different public health problems such type 2 diabetes as well as on rare diseases. To attain this goal, this mini-review dedicated to structural 
and chemical investigations and based on selected and recent data collected through techniques using third generation synchrotron radiation as 
a probe is proposed to the reader.
Keywords: physicochemistry, medicine, pathological calcifications, lithiasis, kidney stones, Randall’s plaque, synchrotron, infrared spectroscopy, 
UV-visible spectroscopy, X-ray fluorescence, X-ray absorption
Introduction
Pathological calcification (PC) occurs frequently in 
medicine.1–4 A large part of the literature has tried 
to demonstrate a causal relationship between PC 
and pathology. Also, it is worth underlining that 
controversies exist regarding this l ink. A well-
established relation between calciphylaxis (calcium 
deposits in the vascular walls) and deleterious 
consequences such as an increased mortality in 
affected patients) has been reported in patients 
suffering end stage renal failure.5 Gout cases related 
to the crystallisation of sodium hydrogen urate in 
synovial fluid are well documented.6 Renal failure 
due to crystalline deposits within the kidney was 
reported in a variety of diseases resulting in the 
crystallisation of poorly soluble substances excreted 
by the kidney. Regarding prostate tissue, it is common 
to find calcium deposits without any obvious relation 
to the pathology (prostate hypertrophy, adenoma or 
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cancer).7,8 Note that the link between calcification and 
pathology could be the crystalline species identified 
within the tissue. For example, breast tumours may 
be associated with weddellite crystals or with calcium 
phosphate deposits. It was reported that tumours are 
benign in the case of calcium oxalate and benign or 
malignant in the case of calcium phosphate.9–11
In the medical literature, papers consider that PCs 
are made mainly of calcium and distinguish two forms 
of PC. This dystrophic one occurs in dying and dead 
tissue. It is well known that injured and dying cells 
are not able to maintain normal calcium homeostasis, 
leading to an increase of intracellular calcium levels. 
The second family, the metastatic calcifications, are 
associated with elevated extracellular levels of calcium 
(hypercalcemia), exceeding the homeostatic capacity 
of cells and tissues. These two definitions are based 
on the metabolism of calcium. Unfortunately, more 
than 100 chemical phases have been identified in 
PC and most of them do not contain calcium.2,4 Such 
experimental facts call for another classification based 
on their pathogenesis process.
We have proposed a more general classification 
for PC made of three families.1–4 First, concretions 
which are found in hollow organs or ducts of 
the body. For example, kidney stones are solid 
concretions of dissolved minerals in urine.12–15 In 
the case of concretions, crystallisation is induced in 
metastable supersaturated solutions by spontaneous 
nucleation when a certain degree of supersaturation 
is reached (homogeneous nucleation). In contrast, 
ectopic calcifications are defined as unexpected 
biomineralisation occurring in soft tissues. It is 
worth underlining that metastatic and dystrophic 
calcifications can be considered ectopic calcifications. 
We may have PCs related to homogeneous and 
heterogeneous nucleation. This is the case of kidney 
stones attached at the surface of Randall’s plaque 
(RP). Crystallites in urine (homogeneous nucleation) 
are agglomerated at the surface of RP which serves 
as a nucleus (heterogenous nucleation).16 A third 
family can be related to physiological calcifications 
(otoliths, tooth,17 bone) which becomes pathological 
with diseases (bone and osteoporosis18,19).
In fact, several questions should be answered in the 
case of crystal deposits within a tissue: what is the 
accurate composition of the crystal? Is the crystal a 
specific marker for a pathology? What is the interaction 
between the crystal and the tissue? Physical methods, 
including ones implemented on synchrotron facilities, 
may be of a valuable help to answer all these questions 
(see, for example, Reference 20).
A clinical case based on 
synchrotron data
We start this review with the presentation of a clinical 
case where the characterisation of PC1–4 through µFT-IR 
(Fourier transform infrared) spectroscopy performed on 
the SMIS (Spectroscopy and Microscopy in the Infrared 
region using Synchrotron) beamline of the SOLEIL (Source 
Optimisée de Lumière d’Energie Intermédiaire du LURE) 
Synchrotron plays a pivotal role. A 64-year-old woman 
was admitted to a nephrology unit for rapidly progressive 
renal insufficiency with an increased serum creatinine 
level of about 500 µmol L–1 giving an estimated glomerular 
filtration rate of 10 mL min–1/1.73 m2. Such a high value 
for serum creatinine corresponds to a severe impairment 
of kidney function (normal value >90 mL min–1/1.73 m2). 
The analysis of her medical file revealed a well-controlled 
hypertension diagnosed 10 years before as well as a 
chronic renal failure diagnosed 2 years before with a 
serum creatinine at 215 µmol L–1. This chronic renal 
failure was attributed to nephroangiosclerosis, a disease 
related to hypertension. The fact that this rapidly 
progressive renal insufficiency failure was not associated 
to an obvious cause led to a renal biopsy (RB). RB is 
often necessary for diagnosis, prognostic assessment 
and therapy guidance of various diseases affecting native 
and transplanted kidneys.21 The final diagnosis differs 
from the main hypothesis in up to one-third of cases.22 
The observation through an optical microscope of the RB 
shows an extensive tubulo-interstitial fibrosis scattered 
with multiple small crystallites. For this patient, such 
observation was definitely not able to determine the 
chemical nature of these small crystallites (Figure 1.A1).
At this point, it is worth emphasising that more than 
20 chemical compounds have been identified including 7 
different calcium salts.23 Thus, the methods used in the 
hospital setting to gather information on PC in RB are 
clearly inappropriate. These methods based on staining 
procedures such as von Kossa staining display some major 
limitations for the characterisation of ectopic calcifications. 
It was reported that such staining procedures are not 
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Figure 1. A1, abnormal deposits observed in the tubular cells and interstitium using an optical 
microscope. A2, evolution of the kidney function as given by the serum creatinine. After a RB, 
µFT-IR experiments were performed at the SMIS beamline of the SOLEIL Synchrotron. Then, 
after identifying the crystals as dihydroxyadenine (DHAd), a specific treatment with allopurinol 
was started and the serum creatinine decreased significantly. In order to illustrate the difficulty to 
perform a significant medical diagnosis, we show in B and D, whewellite crystallites, while in C and 
E, DHAd ones are shown. Let us recall that these two chemical phases are related to very different 
pathologies and thus very different medical treatment. Such similarity calls for a characterisation 
through a physicochemical technique such µFT-IR spectroscopy.
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sufficient for identifying and quantifying apatite to assess 
bone formation.24
Regarding the patient, a genetic investigation is also an 
option to perform a significant diagnosis. Unfortunately, 
the cost of such investigation is high. Also, it requires 
quite a long time. Note that such an approach through 
genetics must be guided by clinical and biological 
data. Here an accurate characterisation of the crystals 
found within the tissue gives key information to the 
clinician. To identify the chemical nature of the small 
crystallites, we selected µFT-IR spectroscopy and went 
to the SMIS beamline of the SOLEIL Synchrotron to 
perform such an experiment. Quickly, the presence 
of 2,8-dihydroxyadenine (DHAd) was identified in 
the kidney biopsy. This compound is produced by the 
body when it is unable to recycle adenine.25 This early 
diagnosis based on synchrotron data made all the 
difference. The medical treatment (now allopurinol or 
febuxostat) of the disease thus identified is available 
and was applied at once. The kidney function of the 
patient finally recovered. Such diagnosis changed 
significantly the life of the patient because it was not 
necessary for her to have dialysis and thus a kidney 
transplantation. This clinical case has been reported on 
different websites26 and published.27
From a financial point of view, the cost of an 
undiagnosed case leading to end stage renal failure 
is at least 85 k€ per year for dialysis (the average time 
before kidney transplantation is about 18–24 months), 
85 k€ for the kidney graft (around 3100 kidney 
transplantations per year in France), and finally 10 k€ 
per year of medical therapy, management of side 
effects and follow-up of the patient. By comparison, 
the cost of 8 h synchrotron use to establish a clinically 
relevant diagnosis is 4 k€ (half an hour is in fact 
sufficient) while the price of a last generation in-lab 
µFT-IR spectrometer is around 300 k€ and the cost 
of an analysis on this equipment is around 160 €. In 
conclusion, the patient saves her kidney and social 
security saves some money (more than 350 k€).28
Thanks to different state agencies, two in-lab µFT-IR 
spectrometers allowing us to perform experiments very 
similar to the one performed on SMIS have been installed 
at the physiology unit of Tenon Hospital. This clinic case 
was thus the starting point of a large survey on grafted 
patients (more than 300 patients are engaged in this 
investigation) in collaboration with Huriez Hospital, Lille, 
France. The first patient for which the µFT-IR measurement 
was performed at Tenon Hospital was a four-year old girl 
already transplanted and who presented with a kidney 
graft dysfunction. She had DHAd crystallites present 
in the RB. Thanks to an early diagnosis of the crystals 
using µFT-IR spectroscopy, she received allopurinol and 
she recovered her kidney graft function. At this point, 
it is worth underlining that since the installation of this 
apparatus at the Tenon Hospital, 18 patients have been 
diagnosed with the same pathology.
This preamble shows clearly that PC constitutes 
an exciting entry point for physicists and chemists in 
medical research. Regarding the interface between 
physics and medicine, let us note that the first medical 
application of X-rays was made by W.C. Röntgen in 1895 
through an image of a left hand; this image was in fact 
the discovery of X-rays. Now, part of the cutting-edge 
research done in medicine is performed on numerous 
beamlines implemented on several synchrotron radiation 
centres.29–31 At SOLEIL, the French synchrotron facility, 
the first experiment was performed on kidney stones.32 
Note that a beamline of the European Synchrotron 
Radiation Facility (ESRF) is dedicated to research in 
medicine.33–35
One of the key points of the research dedicated 
to PC is linked to the relationship between the 
pathology which induces such biological entities 
and their physicochemical characteristics.12,13,36–38 
Such a relationship allows the clinician to establish 
an early diagnosis and also to develop new drugs.39 
In this review, we would l ike to present some 
recent publications related essentially to PC which 
illustrate the interest of the medical community in 
synchrotron radiation. To attain this goal, we will start 
with some generalities regarding PC.40,41 Then we 
will present succinctly different techniques, namely 
X-ray fluorescence,42 scattering techniques,43 X-ray 
absorption spectroscopy,44,45 FT-IR spectroscopy46,47 
and  UV-v i s ib le  spect roscopy. 48 ,49 For each 
characterisation tool, some examples will be given.
Some generalities of PCs
Ubiquity of the PC
PC may occur in various parts of the body, namely 
kidneys,12–16 arteries,50,51 breast,52–54 gallbladder,55,56 
liver,57 pancreas,58,59 prostate,60,61 saliva,62 thyroid,63 
heart64 and cartilage.65–68 Calcifications may occur also 
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Figure 2. Ubiquity of PC. This figure shows the different locations for the PC we have selected in our research.
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on medical devices namely bioprosthetic heart valves,69 
mammary implants,70 stents71,72 and intraocular lens.73 
In Figure 2, we present the different organs we have 
selected for our research on PC. Such approach allows us 
to assess the different models proposed by the clinician 
for the pathogenesis of the PC.
For example, in a translational investigation dedicated 
to the calcifications present in the vessel wall, the data 
suggest that free DNA coming from cell lysis could 
be involved in the very first steps of the pathogenesis 
of these biological entities.50 The formation of kidney 
stones is principally related to supersaturation.12,13 Such 
considerations demonstrate clearly that only a strong 
relationship between physico-chemist and physicists may 
lead to significant breakthroughs.
Finally, such set of samples allows us to consider 
different types of pathologies and in Figure 3 we show 
different images obtained on a scanning electron 
microscope corresponding to kidney infection,74 breast 
cancer,75 iatrogenic76 and genetic diseases.77,78
Figure 3. PC are observed for very different pathologies encompassing cancer, infection, genetic 
disorders and iatrogenic diseases.
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A huge chemical diversity
Various medical papers and presentations assume that 
PC is a lesion in which calcium salts, usually in the form 
of calcium phosphate with an apatite structure, are 
deposited abnormally in soft tissues.79 The analysis of the 
literature shows that this point does not take into account 
the huge chemical diversity of these biological entities. 
Uric acid80 as well as amino acids such as cystine81–84 
have been identified in PC. Such biological entities may 
also have an exogenous origin. For example, in kidney, 
drug-induced renal calculi have been identified76 and 
drug crystals in tubules of the kidney have been identified 
as the cause of kidney injury.85,86 Other drug crystals 
responsible for tissue lesions have been reported in the 
gut.87 Finally, some silica objects have been identified 
in the centre of granuloma present in skin and also in 
kidney stones.88–91 In a recent publication, following a 
demand from a dermatologist, we analysed abnormal 
deposits present on the surface of hairs. We pointed out 
the presence of titanium dioxide.92
Characterisation of PCs
From micrometre scale to nanometre scale
The starting point of this research dedicated to PC has 
been performed essentially at the micrometre scale 
using mainly in-lab characterisation techniques.93,94 
More precisely, two characterisation tools have been 
used namely field emission scanning electron micros-
copy23 and µFT-IR spectroscopy.93 The definition of such 
approach was made on the basis of the morphocon-
stitutional model.12 Then, we begin a physicochemical 
description at the nanometre scale based on different 
techniques using synchrotron radiation as a probe.95 At 
the nanoscale, major information can be obtained on 
the pathogenesis of kidney stones.96,97 In our case, we 
have used several experimental setups to characterise or 
mimic the pathogenesis process.98,99 Among them, let us 
highlight transmission electron microscopy97 and nuclear 
magnetic resonance100 (Figure 4).
As can be seen in Figure 5, such approach has been 
used to study Wilson’s disease (WD), theranostic 
vectors, as well as for the interaction between tea 
and kidney stones. For example, we have proposed an 
X-ray fluorescence (XRF) spectroscopy-based approach 
on liver tissue as a diagnostic tool for WD, also known 
as hepatolenticular degeneration, which is a severe 
disorder of copper homeostasis caused by mutations in 
the gene ATP7B encoding a copper-transporting P-type 
ATPase.101 Also, a new rapid scan method, Flyscan mode, 
implemented on the DiffAbs beamline102 at SOLEIL 
Synchrotron which allows fast µXRF data acquisition 
has been used to gather a complete set of data acquired 
after injection of gold-cluster-enriched mesoporous silica 
nanospheres, used as potential theranostic vectors, into 
rats.103 Finally, we have recently performed a study to 
assess the possible interaction between green tea, which 
is widely used as a ‘’healthy” beverage due to its high level 
of antioxidant polyphenol compounds, and kidney stones 
made of calcium oxalate. Our data show no evidence for 
increased stone risk factors or oxalate-dependent stones 
in daily green tea drinkers.104
Fourier transform infrared 
spectroscopy
FT-IR spectroscopy has been proved to be a powerful 
characterisation tool for investigations on inorganic as 
well as organic chemical compounds in both qualita-
tive and quantitative modes.46,47 This technique is non-
destructive and label-free. FT-IR spectroscopy probes 
vibrational energy levels providing chemical as well as 
structural information by comparison with database 
reference spectra.105–107 The formalism associated with 
classical µFT-IR spectroscopy indicates that the spatial 
resolution is limited by the diffraction, its value being 
around 5 µm. Recently, FT-IR spectroscopy has been 
combined with atomic force microscopy to break through 
the diffraction limit leading to a spatial resolution of 
20–40 nm.108,109
Nowadays, FT-IR spectroscopy is routinely used 
at several hospitals. Among these, we can cite the 
characterisation of lipids in graft liver at the Paul Brousse 
hospital,110 of concretions and ectopic calcifications in 
kidney biopsies for 30 years at the Necker hospital and 
subsequently at the Tenon Hospital.111,112 Thanks to 
the morphoconstitutional model,12 which is a significant 
relationship between the physicochemical characteristics 
of urinary stones and the pathology which induces 
the formation of these biological entities, different 
epidemiologic breakthroughs have been made.
For example, a specific morphology for apatite kidney 
stones has been observed in 96.1 % of stones associated 
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with inherited distal renal tubular acidosis.113 In contrast, 
other stones of similar composition but different 
morphologies observed through optical microscopy were 
related to distal renal tubular acidosis in only 3.9 % of 
cases. Also, the distribution of the main stone components 
was analysed in a series of 2464 calculi from 272 (11 %) 
patients with type 2 diabetes and 2192 without type 2 
diabetes. The proportion of uric acid stones was 35.7 % 
in patients with type 2 diabetes and 11.3 % in patients 
without type 2 diabetes (p < 0.0001).114 Another example 
is provided by kidney stones related to infection.74 
FT-IR spectroscopy data have clearly established that 
Figure 4. Different experimental devices to characterise PC. Several beamlines 
implemented at SOLEIL Synchrotron, namely AILES, CRISTAL, DIFFABS, DISCO, 
NANOSCOPIUM, SMIS have been used. Also, we have used ID21 on the ESRF Synchrotron 
and G4.1 at the Laboratoire Léon Brillouin (LLB).
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Figure 5. a–d, spatial distribution of different elements, respectively, Zn, Fe, Au, Ca obtained during an 
investigation of quantum rattle based on gold quantum dots. We can see clearly the mouse’s kidney. e–h, 
spatial distribution of different elements, respectively Zn and Pt, for two patients who received an injec-
tion of Pt-based anti-cancer drugs. Statistical analysis of the data allows the clinician to assess inflamma-
tion, i–l. For the two samples, classical staining procedures show the samples are not associated with WD, 
while XRF shows a significant increase of the Cu signal for WD. XRF, thus, constitutes a more sensitive 
technique than the classical ones and offers the opportunity for the clinician to perform an early diagnos-
tic test.
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stones resulting from urinary tract infection due to 
urea-splitting bacteria consist of calcium phosphate 
hydroxyapatite admixed with struvite and exhibit a high 
CO32– content.115,116 Finally, as mentioned previously, 
several papers show the large chemical diversity of the 
abnormal deposits in kidney biopsies.117–119
In Figure 6, we use the fact that high spatial resolution 
infrared mapping constitutes a very powerful tool 
to study the kidney distribution of foscarnet and 
metabolites. It is well known that foscarnet crystallises 
in glomeruli.27 Foscarnet (phosphonoformic acid) 
is a pyrophosphate analogue that inhibits the DNA 
polymerase of all herpes viruses. Foscarnet is commonly 
used in immuno-suppressed patients (AIDS, grafted 
patients) who have developed cytomegalovirus infection. 
Through µFT-IR performed on the SMIS beamline, we 
confirmed the presence of sodium foscarnet crystals 
in glomeruli. In addition, we found in the cells of the 
proximal tubule a deposit made of calcium phosphate 
apatite. Such experimental data suggest that the drug 
is locally metabolised by splitting the bond between the 
two phosphate residues of foscarnet. To the best of our 
knowledge, no experimental data has been reported 
about crystalline or amorphous chemical phases 
deposited within the cells of the tubules in the kidney.
UV-visible spectroscopy
We discuss another, recent clinical case already presented 
at a conference.120 A 7-month old child, who did not 
present any comorbidities, developed an end stage renal 
failure of unclear origin. The first retained diagnosis was 
acute tubular necrosis secondary to acute dehydration 
in a context of sepsis. Renal ultrasound showed two 
well-differentiated kidneys measuring 57 mm and 69 mm. 
Figure 6. a, optical image of a birefringent structure positioned in glomeruli. b, µFT-IR spectra shows clearly 
the presence of sodium foscarnet in glomeruli. c, µFT-IR spectra shows clearly the presence of apatite in the 
cells of the proximal tubule.
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There was no evidence of malformation or obstruction. 
The cortex was slightly hyperechogenic. Parents are not 
related and they are no known nephropathies in the 
family.
Since she did not recover her kidney function, a 
biopsy was performed five weeks after acute renal 
failure. It revealed tubular impairment with few signs of 
regeneration and persistence of a discrete inflammatory 
infiltrate made of lymphocytes and macrophages. They 
were no glomerular nor vascular lesions. By microscopic 
examination under polarised light, only three small 
(<10 µm) intracellular birefringent crystals were found 
in the tubules (Figure 7a). Infrared microscopy using 
our PerkinElmer infrared spectrometer and synchrotron 
radiation (SMIS beamline) were performed to identify the 
crystals, but the results were inconclusive.
Then, we started an investigation on the DISCO 
beamline.118,121 We started by considering macroscopic 
kidney stones made of calcium oxalate monohydrate 
(COM). The spectrum of these kidney stones has a 
specific signal around 410 nm. Then, we came back to the 
microcrystals present in tissues for the patient discussed 
just above. The spectrum obtained for the biopsy was 
very similar to that of the kidney stones made of COM, 
suggesting that the microcrystals were also made of 
COM (Figure 7b). Finally, we used this specific signal to 
obtain the distribution of oxalate in tissue (Figure 7c). 
Surprisingly, we observed a positive signal in almost 50 % 
of the tubular cells. Such observation takes into account 
that while IR spectroscopy is sensitive only to oxalate 
linked to calcium, UV-visible spectroscopy offers the 
possibility to gather information on oxalate linked or not 
to calcium. UV-visible spectroscopy opens the way to a 
completely new paradigm regarding ectopic calcifications. 
Further work is in progress on a larger number of samples.
X-ray fluorescence
In the photoelectric absorption process, the absorption of 
incident photons leads to the ejection of photoelectrons 
if the photon energy is sufficient. The atomic relaxation 
Figure 7. a, optical image of a birefringent structure. b, UV-visible spectra related to this abnormal 
deposit. c, spatial distribution of oxalate in the tissue obtained through UV-visible data.
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process produce XRF radiation with characteristic ener-
gies of the atom and also other photoelectrons called 
Auger electrons.42 The characteristic energies of the XRF 
radiation emitted from a sample offer the opportunity 
to identify unambiguously and quantify the different 
elements present.
This technique has been used to characterise different 
kinds of PC.122–125 First, note that investigation of 
calcification chemistry is hampered by the difficulty 
of quickly and systematically locating sites. A recent 
publication shows that XRF spectroscopy can be used 
to locate micro-calcifications within tissue specimens.126 
Exciting results have been obtained on the ultrastructure 
of vascular calcifications in uremia. The complete set of 
data suggests that uremic micro-calcifications originate 
from nanocrystals, are chemically diverse and intimately 
associate with proteinaceous inhibitors of calcification.127 
Furthermore, considering the core-shell structure of the 
calcifications, apoptotic bodies or matrix vesicles may 
serve as a calcification nidus. In another investigation, 
the authors examine the presence of Zn, a trace 
element, in osteoarthritis (OA) cartilage and meniscus 
from patients undergoing total knee joint replacement 
for primary OA.128 A fine analysis of the data seems to 
show that Zn2+ cations present in the cartilage belong 
to two chemical species. The first may correspond to 
Zn2+ embedded in protein (several Zn metalloproteins are 
known to prevent calcification in biological tissues). The 
second may be associated with a Zn2+ trapped in or at the 
surface of the calcification.128 Calcification present in OA 
cartilage may significantly modify the spatial distribution 
of Zn2+, part of the Zn may be trapped in the calcification 
and may alter the associated biological function of Zn2+ 
metalloproteins. Finally, synchrotron-radiation-induced 
µXRF analyses can be used to investigate the distribution 
of Pb in human joints.129 The X-ray absorption near-
edge structure (XANES) spectra collected at the Pb LIII 
edge for a microbeam positioned at the tidemark and at 
the trabecular bone were found to be highly correlated 
with the spectra of synthetic Pb-doped carbonated 
hydroxyapatite. The authors suggest that in both of 
these very different tissues Pb is incorporated into the 
hydroxyapatite structure.
Obviously, XRF has other medical applications. In 
our case, we have used XRF to investigate the spatial 
distribution of platinum-based drugs. These molecules 
are widely employed as anti-cancer agents because 
of their efficacy against a variety of tumours, but their 
use is limited by their nephrotoxicity.130 In the first part 
with a dedicated focus on mice, the cisplatin injection 
induced a redistribution of medullary Zn across the 
corticomedullary junction where histological lesions 
develop. These results were confirmed by a quantitative 
approach based on an evaluation of Pearson’s and 
Manders’ co-localisation coefficients. The data suggest 
that the spatial distribution of Zn2+ cations and more 
precisely its correlation with platinum can be used to 
evaluate the nephrotoxicity of cisplatin. This could 
lead to new diagnosis, physiopathological and even 
therapeutical approaches.131 Regarding the investigation 
on human biopsy, we were able to discuss the spatial 
repartition of Pt and Zn in RB. Therefore, µXRF could 
also be of major interest to decipher the mechanism 
beyond Pt-induced neurotoxicity, ototoxicity on human 
biopsy.132
X-ray absorption spectroscopy 
(XAS)
Due to its ability to give structural and electronic infor-
mation on materials without long range order, such as 
clusters or molecules,44,45,133–135 XAS has made major 
contributions to a wide variety of medical research 
topics.136,137 More precisely, C.M. Weekley et al. have 
combined XAS and XRF techniques to assess the problem 
of selenium speciation in biological systems.138 More 
recently, XAS experiments have brought major informa-
tion regarding a progressive neurodegenerative disease, 
namely Friedreich’s ataxia.139
XAS is a direct probe of atomic distribution via electron 
diffraction. One of the key successes of XAS comes from 
the fact that last generation synchrotron sources provide 
a range of X-ray energies with a microbeam that are 
applicable to most elements in the Periodic Table.
More precisely, we may distinguish two parts of 
the X-ray absorption spectrum: XANES and extended 
X-ray absorption fine structure (EXAFS).44,45 XANES 
corresponds to the measurement of transitions from core 
electronic states of the metal to the excited electronic 
states, while EXAFS corresponds to a transition to the 
continuum. XANES and EXAFS spectroscopies give 
complementary structural and electronic information. 
The XANES part describes the electronic structure and 
symmetry of the metal site, while the EXAFS part gives 
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a fine description of numbers, types and distances to 
neighbouring atoms from the absorbing element. 
Note that for nanometre scale metallic cluster, EXAFS 
spectroscopy is insensitive to polydispersity.140
Regarding kidney stones, the study of RP constitutes 
a major research topic. Based on extensive forensic 
studies performed on kidney between 1935 and 1938, 
A. Randall, an American urologist, observed, at the tip 
of the renal papillae, an abnormal deposit of calcium 
phosphate (named RP).141 A precise observation of 
these RPs indicate that these PCs serve as a nidus 
of kidney stones.142,143 As this point, it is worth 
underlining that calcium oxalate stone incidence has 
increased worldwide during the past decades.143,144 
The observation that a growing number of kidney 
stones are related to RP has motivated a large 
number of investigations based on last generation 
characterisation techniques (see, for example, recent 
References 145 and 146).
Through XAS performed at the Ca K-absorption edge, 
a technique specific to synchrotron radiation (Figure 
8), the presence and crystallinity of the Ca phosphate 
phases present in RP were determined ex vivo.147 Direct 
structural evidence of the presence of amorphous 
carbonated calcium phosphate (ACCP) as a major 
constituent is given for the first time. This set of XANES 
data obtained on ex vivo samples, coherent with previous 
studies performed on RP extracted from kidney stones, 
shows that this chemical phase can be considered as 
one precursor in the genesis of RP. From a biochemical 
Figure 8. a, photograph of the DIFFABS beamline. b, photograph of the RP positioned at the top of the 
papilla. c, XANES spectra at the Ca K-edge of two RPs (dotted lines) is compared to reference com-
pounds; synthetic well-crystallised stoichiometric Ca phosphate apatite (HAP, red curve), crystallised 
biological Ca phosphate apatite (CA, blue dots) exhibiting nm-sized crystals, amorphous carbonated 
calcium phosphate (ACCP, black curve with circles).
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point of view, it is worth pointing out that in the kidney 
ACCP is considered as evidence of an oversaturation in 
Ca phosphate by an excess of Ca and/or phosphate and/
or due to a too high pH. Such chemical compositions of 
RP present in increasingly young subjects raises a major 
question regarding public alimentation: does nutrient-
enriched food with calcium and vitamin D specially aimed 
at young children affect the physiology of the kidney? 
The question is open.148,149
X-ray and neutron scattering
Since the first experiment carried out using a classical 
vacuum tube at the beginning of the previous century, 
X-ray diffraction (XRD) has emerged to be one of the 
most powerful characterisation techniques in almost 
every field of science and technology. Many books 
and several review articles have been dedicated to the 
numerous methods of characterisation linked to X-ray 
scattering.43,150 Basically, scattering techniques can be 
used either to determine the crystal structure or the 
chemical composition of the samples through the powder 
diffraction bank data file. As previously underlined, FT-IR 
spectroscopy can also give the chemical composition, but 
XRD and FT-IR display advantages as well as limitations. 
XRD gives the size of the crystal for each chemical phase 
which are identified, but this technique is only sensi-
tive to chemical phases with long range order.43 FT-IR is 
sensitive to amorphous and crystallised compounds and 
gives some important structural characteristics such as 
the carbonate level of apatite. This structural character-
istic is of major importance to establish a possible infec-
tion involved in stone formation.
Regarding kidney stones, we have used scattering 
techniques to determine structural characteristics of 
different unknown chemical phases present in kidney 
stones.151–153 The identification of a new compound in 
kidney stones is relevant in clinical practice. Such a new 
chemical phase is often related to a new kidney disease.
In order to determine the crystal’s size in the case 
of kidney stones made of COM,154 cystine83 and uric 
acid,155 we have used neutron scattering.156 More 
generally, because neutrons do not significantly damage 
biological solids such as kidney stones, they offer the 
opportunity to investigate bulk biological samples, 
whether as an aqueous solution, a solid, a powder or a 
crystal. Neutron scattering uniquely complements other 
characterisation techniques, and together with X-ray 
synchrotron analysis, is considered among the most 
useful microscopic probes of matter available today.157 
Unlike X-rays, they do not interact with the electronic 
cloud of an atom, but with its nucleus: the strength 
and character of this neutron–nucleus interaction is 
characterised by the so-called neutron scattering length. 
This neutron scattering length varies irregularly from 
one nucleus to another. In particular, this parameter is 
quite significant for light elements like hydrogen, carbon, 
nitrogen or oxygen, which are almost invisible to X-rays. 
Neutrons like photons and electrons constitute thus an 
important probe in the investigation of the matter and 
especially in the location and dynamics of protons, an 
essential aspect in many biological processes.
Among the different key results we have obtained using 
neutrons as a probe, we will discuss the ones related 
to uric acid kidney stones.155 As noticed previously, 
recent epidemiological investigations have identified 
an association between type 2 diabetes and uric acid 
kidney stones.114,155 Such a relationship is more apparent 
in women than in men. Through powder neutron 
diffraction,156,157 we have shown that particle sizes 
of uric acid kidney stones were significantly different 
between male and female patients (84.7 nm ± 5.3 nm 
vs 140.2 nm ± 6.7 nm, p = 0.000003). When we consider 
male and female patients with type 2 diabetes, this 
structural difference between male and female vanished 
(76.1 nm ± 3.9 nm vs 78.8 nm ± 4.2 nm, not significant). 
We try to explain these structural data obtained on kidney 
stones and based on neutron scattering experiment, in 
line with observations regarding epidemiological data on 
arguments based on supersaturation.
Conclusion and perspectives
This mini-review dedicated to research performed on 
PC shows clearly an exciting meeting between physics, 
chemistry and medicine. Due the complexity of such 
biological entities which contain organic and inorganic 
parts in which trace elements are present, different 
in-lab characterisation techniques are used. Analysis 
at the micrometre scale is carried out by techniques 
using synchrotron radiation as a probe, which gives the 
opportunity to describe the structural characteristics of 
human calcification at the nanometre scale. Note that 
we have also performed very exciting investigations 
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on cells158 and mice.84,131,159–161 Finally, it is worth 
underlining that fundamental research performed on 
the adsorption of molecules on clusters is also carried 
out.162–165 Such a fundamental approach will help us to 
understand how molecules interact with nanocrystals 
and modify their morphology.
In conclusion, results obtained with synchrotron radiation 
have been used to develop new diagnostic methods and 
to understand more deeply the pathogenesis process of 
PC. Second, a technology transfer has been done in order 
to perform similar experiments at the hospital. It is worth 
underlining that more than 1600 kidney biopsies have 
been characterised following the publication in PLoS ONE 
dedicated to kidney biopsies in close collaboration with 
SOLEIL Synchrotron.27 To attain this goal, we performed 
the measurements with young doctors, namely Dr E. 
Bouderlique (Nephrologist), Dr F. Brunet-Possenti 
(Dermatologist), Dr X. Carpentier (Urologist), Dr R. 
Coscas (Cardiologist), Dr H. Colboc (Dermatologist), Dr E. 
Estève (Nephrologist), Dr A. Gauffenik (Rheumatologist), 
Dr J. Guerlain (Otorhinolaryngologist), Dr R. Kormann 
(Nephrologist), Dr M. Livrozet (Nephrologist), Dr Y. Luque 
(Nephrologist), Dr Ch. Nguyen (Rheumatologist), Dr 
B. Pradère (Urologist), Dr C. St Jacques (Nephrologist), 
Dr C. Verrier (Urologist) and Dr V. Masson-Behar 
(Rheumatologist), who finally have the opportunity to 
define completely new research topics.
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